Abstract

Ideally, endoscopists should be able to detect, characterize, and confirm the nature of a lesion at the bedside, minimizing uncertainties and targeting biopsies and resections only where necessary. However, under conventional white-light inspection – at present, the sole established technique available to most of humanity – premalignant conditions and early cancers can frequently escape detection. In recent years, a range of innovative techniques have entered the endoscopic arena due to their ability to enhance the contrast of diseased tissue regions beyond what is inherently possible with standard white-light endoscopy equipment. The aim of this review is to provide an overview of the state-of-the-art advanced endoscopic imaging techniques available for clinical use that are impacting the way precancerous and neoplastic lesions of the gastrointestinal tract are currently detected and characterized at endoscopy. The basic instrumentation and the physics behind each method, followed by the most influential clinical experience, are described. High-definition endoscopy, with or without optical magnification, has contributed to higher detection rates compared with white-light endoscopy alone and has now replaced ordinary equipment in daily practice. Contrast-enhancement techniques, whether dye-based or computed, have been combined with white-light endoscopy to further improve its accuracy, but histology is still required to clarify the diagnosis. Optical microscopy techniques such as confocal laser endomicroscopy and endocytoscopy enable in vivo histology during endoscopy; however, although of invaluable assistance for tissue characterization, they have not yet made transition between research and clinical use. It is still unknown which approach or combination of techniques offers the best potential. The optimal method will entail the ability to survey wide areas of tissue in concert with the ability to obtain the degree of detailed information provided by microscopic techniques. In this respect, the challenging combination of autofluorescence imaging and confocal endomicroscopy seems promising, and further research is awaited.

Highlights

  • Cancer of the gastrointestinal (GI) tract is the leading cause of cancer death worldwide.[1]

  • Prevention is based on early endoscopic detection of potentially curable cancers or precursor conditions such as dysplasia, which have a significant risk of progression to malignancy.[2]

  • Another study from Japan showed that the florescence intensity of images acquired using an autofluorescence imaging (AFI) system is inversely proportional to the degree of dysplasia in colonic adenomas.[90]

Read more

Summary

Introduction

Cancer of the gastrointestinal (GI) tract is the leading cause of cancer death worldwide.[1]. Extensively referenced studies describing the use of clinically approved commercially available techniques, as defined by the Tajiri and Niwa classification of endoscopic imaging,[36] and investigating the detection/evaluation of GI dysplasia and early cancers, were included. Another study from Japan showed that the florescence intensity of images acquired using an AFI system is inversely proportional to the degree of dysplasia in colonic adenomas.[90] This study suggested that the dysplastic changes, including an increased number and density of cells and crypts, and the enlargement of nuclei and crypts, might somehow alter the tissue permeability and jeopardize the way back to the surface of the emitted fluorescence.

Objective
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call